Additionally, HH-F3 was demonstrated here to attenuate the hyper-phosphorylation of Tau proteins at Ser214 in all AD-iNs, including iAPOE(ε4/ε4), iPS1(P117L) and iAPP(D678H), and a control iN2. This evidence concerns the gene MAPT and Alzheimer disease.